BEHANDLUNG POSTOPERATIVER CHIRURGISCHER SCHMERZEN

Patent europeic · EP4181943 · En vigur

Inscripziun en il register

Numer da publicaziun: EP4181943
Numer da la dumonda: EP21746543
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: En vigur
Scrittira da patent: Concedì
Annunzià: 16-07-2021
Publitgà: 24-05-2023
Concedì: 17-12-2025
La protecziun finescha il pli tard: 15-07-2041
Proxima taxa annuala scadenta: 31-07-2027
Classas IPC: A61K 38/16 (2006.01)
A61K 38/48 (2006.01)
A61P 29/02 (2006.01)
A61P 25/22 (2006.01)
Prioritad: GB 202011055 17.07.2020
Dumonda PCT: PCT/GB2021/051838 16.07.2021
Publicaziun PCT: WO2022/013575 20.01.2022
Lingua da l’annunzia: englais
Funtauna: Swissreg

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

30-09-2026
Midada
Published in Swissreg on 30.09.2026
01-08-2026
Next annual fee due on
Next annual fee due on
31.07.2026 → 31.07.2027
Published in Swissreg on 01.08.2026
26-01-2026
Represchentant inscrit
Representative
Isler & Pedrazzini AG, Postfach, 8027 Zürich
Published in Swissreg on 26.01.2026
17-12-2025
Concedì
Specification status
Non-published patent application → Granted patent
Status of protective title
Initiated → Active
Published in Swissreg on 17.12.2025

Ipsen Biopharm Limited

Unit 9, Ash Road Wrexham Industrial Estate, Wrexham LL13 9UF, GB

Postfach, 8027 Zürich